Abstract. Diabetes often correlates with tau phosphorylation and the development of Alzheimer's disease. Both are associated with brain cholinergic dysfunction that could benefit from nerve growth factor (NGF)-based therapies. Electroacupuncture (EA) improves brain NGF availability and action. Here we assessed the variations of NGF and tau phosphorylation in the cortex and hippocampus, as well as the expression of choline acetyltransferase in the basal forebrain following diabetes induction and EA in adult rats. We found that EA counteracts diabetes-associated tau hyperphosphorylation and decreases in NGF and choline acetyltransferase, suggesting a possible beneficial effect of EA on brain cholinergic system in diabetes.
INTRODUCTION
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A link is emerging between diabetes and brain while EA counteracted this effect (Fig. 1A) . TrkA and
134
ChAT almost completely co-localized in the medial 135 septum (Fig. 1B) (Fig. 1C) .
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Tau hyperphosphorylation
141
Western blots for tau and four different phospho-142 tau epitopes (see Table 1 ) are shown in Fig. 2A Fig. 2 . EA counteracts the STZ-induced variation in tau and tau kinases phosphorylation in the brain. Representative western blots for total tau, phosphorylated tau (see Table 1 for a list of epitopes investigated) and GAPDH as loading control in the cortex (A) and hippocampus (B) of Controls, diabetic (STZ), EA-treated healthy (EA), and EA-treated diabetic rats (STZ + EA). Representative western blots for total and phosphorylated (Ser9)-GSK3␤ (p-GSK3␤) and phosphorylated (Thr180Tyr182)-p38 (p-p38) kinases and GAPDH in the cortex (C) and hippocampus (D) of experimental groups. Graphs show the results of quantitative densitometry with GAPDH integrated optical density used as normalization factor. Statistics were performed on four separate gel run/blots over different sets of two samples for each experimental group (n = 8). Results are presented as mean ± S.D., * p < 0.05 versus Controls, # p < 0.05 versus STZ. Cortex: The ratio between AD2, AT8, and total tau (A) increased after diabetes induction, indicating hyperphosphorylation of the two epitopes, and reverted to baseline by EA (STZ + EA versus STZ, p < 0.05; STZ + EA versus Controls, p > 0.05). STZ also induces a decrease of the p-Gsk3␤/Gsk3␤ and an increase of p-p38/p38 ratios in the cortex (C, STZ versus Controls, p < 0.05), indicating a diabetes-associated increase in the activity of the two kinases. Both of the mentioned alterations in kinases phosphorylation were counteracted by EA (STZ + EA versus STZ, p < 0.05 
